Neuren Pharmaceuticals (ASX:NEU) announces changes leadership team - Sequoia Direct Pty Ltd

27MayMay 27, 2020

Neuren Pharmaceuticals (ASX:NEU) announces changes leadership team

Neuren Pharmaceuticals (ASX:NEU) today announced the appointment of Jon Pilcher and Patrick Davies as Chief Executive Officer and non-executive Chair respectively.

These changes follow Richard Treagus’ decision to stand down after over 7 years as Executive Chairman to enable him to focus on his other business interests.

Jon started at Neuren as CFO in 2013 and is ideally suited to lead Neuren as it moves forward to realise the value of two drugs across multiple childhood disorders with urgent unmet need.

Patrick joined the Neuren board as a non-executive director in July 2018.

His experience includes 10 years as CEO of EBOS Group (formerly Symbion) during which the enterprise value grew from $450 million to more than $3.1 billion.

Shares in Neuren Pharmaceuticals (ASX:NEU) are trading 5.95 per cent higher at $1.78.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

11MayMay 11, 2021

Stocks of the Hour: Crown, The Star, Woolworths & Pointsbet

10 May 2021 - A snapshot of stocks making headlines for the hour featuring Crown Resorts (ASX:CWN), Woolworths (ASX:WOW) & PointsBet Holdings (ASX:PBH).

19DecDecember 19, 2019

Alcidion (ASX:ALC) wins UK contract with NHS

19 Dec 2019 - Digital healthcare business Alcidion (ASX:ALC) has won a contract worth $500,000 over three years to provide patient assessment services to the UK's Taunton and Somerset NHS Foundation Trust.

19SepSeptember 19, 2022

Stocks of the Hour: Micro-X, IVE Group, Origin Energy

19 Sep 2022 - A snapshot of the stocks on the move featuring Micro-X (ASX:MX1), IVE Group (ASX:IGL) and Origin Energy (ASX:ORG).

14AprApril 14, 2020

USFDA grants fee waiver to Cyclopharm (ASX:CYC) for Technegas application

14 Apr 2020 - Cyclopharm (ASX:CYC) is pleased to announce that the United States Food and Drug Administration (USFDA) has granted the Company a full application fee waiver of USD $2.9 million related to its recently submitted New Drug Application (NDA) for Technegas.

25JunJune 25, 2021

Stocks of the Hour: Flight Centre, AMP, Family Zone Cyber Safety

25 June 2021 - A snapshot of notable stock news for the hour, featuring Flight Centre, AMP & Family Zone Cyber Safety.

11AugAugust 11, 2020

Sydney Airport (ASX:SYD) to launch a $2 billion equity raising

11 Aug 2020 - Sydney Airport (ASX:SYD) has launched a $2 billion equity raising after reporting a $53.6 million loss after income tax for the six months to June 30.

12MarMarch 12, 2021

American Pacific Borates (ASX:ABR) suffers loss of over $10.5M for the half

12 Mar 2021 - American Pacific Borates (ASX:ABR) recorded a net loss after tax of over $10.5 million for the half-year ended 31 December 2020.

30AprApril 30, 2020

Regional Express Holdings (ASX:REX) confirms additional funding

30 Apr 2020 - Regional Express Holdings (ASX:REX) has confirmed additional regional services funded by both Federal and State Governments.

16JanJanuary 16, 2023

Stocks of the Hour: eMetals, Ioneer, White Cliff Minerals

16 Jan 2023 - A snapshot of the stocks on the move featuring eMetals (ASX:EMT), Ioneer (ASX:INR) and White Cliff Minerals (ASX:WCN).

16NovNovember 16, 2023

Stocks of the Hour: Galan Lithium, Vulcan Energy Resources, ABx, Bryah Resources

16 Nov 2023 - A snapshot of the stocks on the move, featuring Galan Lithium (ASX:GLN), Vulcan Energy Resources (ASX:VUL), ABx (ASX:ABX) and Bryah Resources (ASX:BYH).